Effects of melatonin in reducing the toxic effects of doxorubicin

Molecular and Cellular Biochemistry

Volumn 286, Issue 1-2, 2006, Pages 11-15

  Öz, Eser ^a,b   İlhan, Mustafa N ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Doxorubicin induced toxicity; Lipid peroxidation; Melatonin

Indexed keywords

ALBUMIN; CREATININE; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; MELATONIN; NITROGEN; UREA; URIC ACID;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CARDIOTOXICITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; LIPID PEROXIDATION; LIVER TOXICITY; LUNG TOXICITY; MALE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; TOXICITY TESTING; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ANIMALIA;

EID: 33646263853     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9003-8     Document Type: Article

References (33)

1. Agapito MT, Antolin Y, del Brio MT, Lopes-Burillo S, Pablos MI, Recio JM: Protective effect of melatonin against adriamycin toxicity in the rat. J Pineal Res 31: 23-30, 2001
2. Olson RD, Mushlin PS: Aoxorubicin cardiotoxicity: analysis of prevailing hypotheses.The FASEB Journal 4: 3076-3086, 1990
3. Rajagopalan S, Politi PM, Sinha BK, Myers E: Adriamycin-induced free radical formation in the perfused rat heart: Implications for cardiotoxicity. Cancer Res 48(17): 4766-4769, 1988
4. Singal PK, Siveski-Iliskovic N, Hill M, Thomas TP, Li T: Combination therapy with probucol prevents adriamycin-induced cardiomyopathy. J Mol Cell Cardiol 27: 1055-1063, 1995
5. Reiter R, Tang L, Garcia JJ, Munoz-Hoyos A: Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 60: 2255-2271, 1997
6. Neri B, de Leonardis V, Gemelli MT, di Loro F, Mottola A, Ponchietti R, Raugei A, Cini G: Melatonin as biological response modifier in cancer patients. Anticancer Res 18: 1329-1332, 1998
7. Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC: Melatonin, hydroxy radical-mediated oxidative damage, and aging: A hypothesis. J Pineal Res 14: 151-168, 1993
8. PieriAC, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55: PL 271-276, 1994
9. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C: Melatonin is a scavenger of peroxynitrite. Life Sci 60: PL 169-174, 1997
10. Li ZR, Reiter RJ, Fujimori O, Oh CS, Duan YP: Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin. J Pineal Res 22: 117-123, 1997
11. Bertuglia S, Marchiafava PL, Colantuoni A: Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 31: 947-952, 1996
12. Duncker DJ, Verdouw PD: Has melatonin a future as a cardioprotective agent? Cardiovasc. Drugs and Therapy 15: 205-207, 2001
13. Montilla PL, Tunez IF, Munoz de Agueda C, Gascon FL, Soria JV: Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats. J Pineal Res 25(2): 86-93, 1998
14. Montilla P, Tunez I, Munoz MC, Lopez A, Soria JV: Hyperlipidemic nephropathy induced by adriamycin: Effect of melatonin administration. Nephron 76(3): 345-350, 1997
15. Rapozzi V, Comelli M, Mavelli I, Sentjurc M, Schara M, Perissin L, Giraldi T: Melatonin and oxidative damage in mice liver induced by the prooxidant antitumor drug, adriamycin. In vivo 13(1): 45-50, 1999
16. Baydas G, Ercel E, Canatan H, Dönder E, Akyol A: Effect of melatonin on oxidative status of rat brain, liver and kidney tissues under constant light exposure. Cell Biochem Funct 19: 37-41, 2001
17. Timlioǧlu Ö, Kutsal Ŝ, Özkur M, Uluoǧlu O:, Aricioǧlu A, Ĉevik C, Düzgün E, Sancak B, Poyraz A: The effect of EGb 761 on the doxorubicin cardiomyopathy. Research Communications in Molecular Pathology and Pharmacology 106: 181-192, 1999
18. Akbulut KG, Gönül B, Akbulut H: Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old rats.Gerontology 45: 67-71, 1999
19. Kurtel H, Granger DN, Tso P, Grisham MB: Vulnerability of intestinal interstitial fluid to oxidant stres. Am J Physiol 263: G573-578, 1992
20. Casini A, Ferrali M, Pompella A, Maellaro E, Comborti M: Lipid reroxidation and cellular damage in extrahepatic tissues of bromobenzene intoxicated mice. Am J Pathol 123: 520-531, 1986
21. Oz E, Erbas D, Sürücü HS, Düzgün E: Prevention of doxorubicin induced cardiotoxicity by melatonin. Molecular and Cellular Biochemistry, in press
22. Booser DJ, Hortobagyi GN: Anthracycline antibiotics in cancer therapy. Drugs 47: 223-258, 1994
23. Grenier MA, Lipshultz SE: Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25: 72-85, 1998
24. Hortobagyi GN: Anthracyclines in the treatment of cancer. Drugs 54: 1-7, 1997
25. PieriAC, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55: PL 271-276, 1994
26. Hardeland R, Reiter RJ, Poeggeler B, Tan DX: The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 17: 347-357, 1993
27. Meister A: Glutathione deficiency produced by inhibition of it's synthesis and it's reversal: Applications in research and therapy. Pharmacol Ther 51: 155-194, 1991
28. Tunez I, del Carmen Munoz M, Feijoo M, Valdervira ME, Rafael Munoz-Castaneda J, Montilla P: Melatonin effect on renal oxidative stress under constant light exposure. Cell Biochem Funct 21(1): 35-40, 2003
29. Tunez L, Munoz MC, Feijoo-Lopez AL, Valdvira E, Bujalance-Arenas L, Montilla P: Effect of melatonin on hyperlipidemic nephropathy under constant light exposure. J Physiol Biochem 58(2): 109-114, 2002
30. Montilla P, Tunez I, Munoz MC, Soria JV, Lopez A: Antioxidative effect of melatonin in rat brain oxidative stress induced by adriamycin. Rev Esp Fisiol 53(3): 301-305, 1997
31. Rapozzi V, Zorzet S, Comelli M, Mavelli I, Perissin L, Giraldi T: Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma. Life Sciences 63(19): 1701-1713, 1998
32. Granzotti M, Rapozzi V, Decorti G, Giraldi T: Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells. J Pineal Res 31: 206-213, 2001
33. Dziegiel P, Suder E, Surowiak P, Jethon Z, Rabczynski J, Januszewska L, Sopel M, Zabel M: Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. J Pineal Res 33: 95-100, 2002